Table 1.
Comparison of baseline characteristics between patients with and without mortality
| Characteristics | Mortality (-) (n = 83) | Mortality (+) (n = 124) | p | All patients (n = 207) |
|---|---|---|---|---|
| Age (year) | 50 ± 11 | 65 ± 11 | <0.001 | 59 ± 13 |
| Male gender (%) | 47 | 43 | 0.571 | 44 |
| Diabetes mellitus (%) | 19 | 52 | <0.001 | 39 |
| Hypertension (%) | 66 | 74 | 0.274 | 71 |
| Current smoking (%) | 6 | 10 | 0.443 | 8 |
| SBP (mmHg) | 140 ± 23 | 149 ± 25 | 0.007 | 145 ± 25 |
| DBP (mmHg) | 81 ± 14 | 79 ± 16 | 0.315 | 80 ± 15 |
| Body mass index (kg/m2) | 23.7 ± 3.6 | 24.0 ± 3.6 | 0.631 | 23.9 ± 3.6 |
| Heart rate (min-1) | 80 ± 14 | 80 ± 12 | 0.725 | 80 ± 13 |
| Albumin (g/dL) | 3.91 ± 0.25 | 3.78 ± 0.29 | 0.002 | 3.83 ± 0.28 |
| Hemoglobin (g/dL) | 9.8 ± 1.2 | 10.0 ± 1.1 | 0.362 | 9.9 ± 1.1 |
| Triglyceride (mg/dL) | 146 ± 93 | 190 ± 147 | 0.009 | 172 ± 130 |
| Total cholesterol (mg/dL) | 184 ± 38 | 186 ± 44 | 0.747 | 185 ± 42 |
| Antihypertensive medications | ||||
| ACEI and/or ARB (%) | 18 | 20 | 0.723 | 19 |
| β-blocker (%) | 17 | 20 | 0.682 | 19 |
| Calcium channel blocker (%) | 27 | 42 | 0.026 | 36 |
| ABI data | ||||
| ABIsbp | 1.14 ± 0.12 | 1.04 ± 0.19 | < 0.001 | 1.09 ± 0.17 |
| ABIdbp | 0.98 ± 0.10 | 0.91 ± 0.16 | < 0.001 | 0.94 ± 0.14 |
| ABImap | 1.06 ± 0.09 | 0.98 ± 0.15 | < 0.001 | 1.01 ± 0.14 |
Abbreviations. ABI, ankle-brachial index; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; DBP, diastolic blood pressure; MAP, mean arterial pressure; SBP, systolic blood pressure.